Elumalal Venkatesan

Title: Elumalal Venkatesan: Innovator in Extended Release Formulations

Introduction

Elumalal Venkatesan is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the efficacy and convenience of medication delivery.

Latest Patents

Venkatesan holds a patent for an extended release formulation of a direct thrombin inhibitor. The patent, titled "Extended release formulations of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide (DPOC-4088)," provides a solution for better control of blood plasma levels. This formulation maintains substantially constant plasma levels of the active ingredient for at least about 16 hours, allowing for once-daily dosing.

Career Highlights

Elumalal Venkatesan is currently associated with Diakron Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has the potential to enhance patient compliance and therapeutic outcomes through improved drug delivery systems.

Collaborations

Venkatesan collaborates with talented professionals in his field, including Sankar Ramakrishnan and Jayanthi Suryakumar. These collaborations foster a creative environment that drives innovation and research.

Conclusion

Elumalal Venkatesan's contributions to the field of pharmaceuticals, particularly through his patented extended release formulations, highlight his role as a key innovator. His work not only advances medical science but also improves patient care through more effective medication delivery systems.